Isoquercitrin alleviates lipopolysaccharide-induced intestinal mucosal barrier damage in mice by regulating TLR4/MyD88/NF-κB signaling pathway and intestinal flora

文献情報

出版日 2023-12-06
DOI 10.1039/D3FO03319H
インパクトファクター 5.396
著者

Enhui Tang, Tong Hu, Zhaokang Jiang, Xiaojun Shen, Huan Lin, Haiyan Xian, Xinlan Wu


原文を見る

要旨

Intestinal mucosal barrier damage is closely associated with the development of several intestinal inflammatory diseases. Isoquercitrin (IQ) is a natural flavonoid compound derived from plants, which exhibits high antioxidant and anti-inflammatory activity with minimal side effects in humans. Therefore, it shows great potential for preventing and treating intestinal mucosal barrier damage. This study aims to investigate the ameliorative effect and mechanism of IQ on lipopolysaccharide (LPS)-induced intestinal mucosal barrier damage in mice. The mice were treated with IQ for 7 days and then injected with LPS to induce intestinal mucosal barrier damage. The results revealed that IQ treatment alleviated LPS-induced intestinal mucosal barrier damage in mice, which can be evidenced by the improvements in intestinal morphology and the promotion of expression in intestinal tight junctions (ZO-1, Claudin-1, and Occludin), as well as MUC2 mucin. IQ also attenuated intestinal inflammatory responses by inhibiting the TLR4/MyD88/NF-κB signaling pathway and reducing the expression and plasma levels of IL-6, IL-1β, and TNF-α. Furthermore, IQ significantly increased the relative abundance of beneficial bacteria, including Dubosiella, Akkermansia muciniphila and Faecalibaculum rodentium, while suppressing the growth of harmful bacteria such as Mucispirillum schaedleri in the intestinal flora of mice. Consequently, IQ can alleviate the LPS-induced intestinal mucosal barrier damage in mice by inhibiting the TLR4/MyD88/NF-κB signaling pathway and modulating the intestinal flora.

関連文献

Modulation of physical properties of supramolecular hydrogels based on a hydrophobic core

Masashi Ohno, Shun Fujita, Kowichiro Saruhashi, Nobuhide Miyachi, Katsuaki Miyaji

2014-11-26 Paper

DOI: 10.1039/C4CP04395B

Complex behaviour of vacancy point-defects in SrRuO3 thin films

Henning Schraknepper, Christoph Bäumer, Regina Dittmann, Roger A. De Souza

2014-11-12 Paper

DOI: 10.1039/C4CP03632H

Measurement and PC-SAFT modelling of three-phase behaviour

Iago Rodríguez-Palmeiro, Oscar Rodríguez, Ana Soto, Christoph Held

2014-11-24 Paper

DOI: 10.1039/C4CP04336G

The role of Schottky barrier in the resistive switching of SrTiO3: direct experimental evidence

Xue-Bing Yin, Zheng-Hua Tan, Xin Guo

2014-11-07 Communication

DOI: 10.1039/C4CP04151H

Ab initio quantum dynamical analysis of ultrafast nonradiative transitions via conical intersections in pyrazine

Manabu Kanno, Yuta Ito, Noriyuki Shimakura, Shiro Koseki, Hirohiko Kono

2014-11-26 Paper

DOI: 10.1039/C4CP04807E

Chemical imaging of single catalyst particles with scanning μ-XANES-CT and μ-XRF-CT

S. W. T. Price, K. Ignatyev, K. Geraki, M. Basham, J. Filik, N. T. Vo, P. T. Witte, J. F. W. Mosselmans

2014-11-05 Paper

DOI: 10.1039/C4CP04488F

Buffers more than buffering agent: introducing a new class of stabilizers for the protein BSA

Bhupender S. Gupta, Mohamed Taha, Ming-Jer Lee

2014-11-06 Paper

DOI: 10.1039/C4CP04663C

Near field plasmonic gradient effects on high vacuum tip-enhanced Raman spectroscopy

Mengtao Sun

2014-11-07 Perspective

DOI: 10.1039/C4CP03871A

Electronic properties of PbX3CH3NH3 (X = Cl, Br, I) compounds for photovoltaic and photocatalytic applications

Sigismund Teunis Alexander George Melissen, Frédéric Labat, Philippe Sautet, Tangui Le Bahers

2014-11-26 Paper

DOI: 10.1039/C4CP04666H

Water and polymer dynamics in a model polysaccharide hydrogel: the role of hydrophobic/hydrophilic balance

V. Venuti, F. D'Amico, A. Gessini, F. Castiglione, C. Punta, L. Melone, V. Crupi, D. Majolino, F. Trotta, C. Masciovecchio

2014-11-11 Paper

DOI: 10.1039/C4CP04045G

こちらもおすすめ

化合物よくある質問

1-{3-[5-(エチルカルボンイル)-2,4-ジメチル-1H-ピロロール-3-基]プロパニル}ピペリジン-4-カルボン酸について、適用される法規ガイドラインは何ですか?

この化合物はCAS番号1142209-81-1であり、GHS分類では corrosive (腐食性物質) と classified (分類物質) として指定され...

1142209-81-11-{3-[5-(Ethoxycarbo...
化合物よくある質問

2,2-二氟-1,3-ベンゾジオキサン-5-カルボキシlic酸とは何ですか?

2,2-二氟-1,3-ベンゾジオキサン-5-カルボキシlic酸は、CAS番号656-46-2の化合物で、化学式はC8H4F2O4です。この化合物は白色の結晶性粉...

656-46-22,2-Difluoro-1,3-ben...
化合物よくある質問

8-氯-4-色原酮の代替品はありますか?

8-氯-4-色原酮(CAS番号: 49701-11-3)の代替品には、他の色原酮類似物や、構造が似ている化合物があります。例えば、8-メチル-4-色原酮や、他の...

49701-11-38-Chloro-2,3-dihydro...
化合物よくある質問

エチル6,6-ジメチル-4,5,6,7-テトラヒドロ-1H-インドアゼー-3-カルボキシレートとは何ですか?

エチル6,6-ジメチル-4,5,6,7-テトラヒドロ-1H-インドアゼー-3-カルボキシレートは、CAS番号1233243-56-5を有する化合物です。これは有...

1233243-56-5Ethyl 6,6-dimethyl-4...
化合物よくある質問

4-叔丁基-6-氯-嘧啶に適用される法規ガイドラインは何ですか?

4-叔丁基-6-氯-嘧啶はCAS番号3435-24-3で、GHS分類では毒性物質とみなし、GHSの危険性分類が適用されます。REACH規則では登録が必要で、Eu...

3435-24-34-Tert-butyl-6-chlor...
化合物よくある質問

維库溴铵杂质Bはどのように合成されますか?

維库溴铵杂质Bは、アンドロステンデンから始まり、一連の合成反応、包括的な選択性と高い収率で合成されます。具体的には、ブロミド化、酸化、ジマーゼ反応、アミド化など...

50587-95-6(2beta,3alpha,5alpha...
化合物よくある質問

2-(4-氟苄基)-吡咯烷の物理化学的性質は何ですか?

CAS番号350017-04-8の2-(4-氟苄基)-吡咯烷は、結晶性の白色粉末です。分子量は199.17 g/molで、水に溶けにくいです。化学反応では比較的...

350017-04-82-(4-Fluorobenzyl)py...
化合物よくある質問

3-喹啉甲醛(2-チロール-8-エチル)は安全ですか?

3-喹啉甲醛(2-チロール-8-エチル)は一定の毒性を持つため、取扱には注意が必要です。使用する際は適切な防護具を着用し、密閉容器で保管・搬送し、直接的な接触を...

335196-05-92-Chloro-8-ethyl-3-q...
化合物よくある質問

エチル3-(ヒドロキシメチル)-1H-ピロール-2-カルボキシレートはどのように保存すればよいですか?

エチル3-(ヒドロキシメチル)-1H-ピロール-2-カルボキシレートは、室温(25℃)以下で保存し、直射日光を避け、乾燥した環境で保管することが推奨されます。ま...

75448-69-0Ethyl 3-(hydroxymeth...
化合物よくある質問

哌拉西林杂质Dは安全ですか?

哌拉西林杂质Dは安全性が確認されていません。使用または取り扱いには注意が必要で、適切な個人防護具を使用し、直接的な接触を避けることが推奨されます。

119410-05-88-Chloro-11-(4-piper...

掲載誌

Food & Function

Food & Function
CiteScore: 10.1
自己引用率: 3.9%
年間論文数: 758

Food & Function provides a unique venue for physicists, chemists, biochemists, nutritionists and other food scientists to publish novel, cutting-edge, original research focussing on food, its nutrients and their relation to human health and nutrition. We welcome research describing the: Physical properties and structure of food and how this relates to sensory perception and human health Biochemical and physiological actions of food components Interactions between foods, gut microbiota and human physiology Nutritional and biological evaluation of food Clinical and population studies using food or food components Development of biomarkers of food intake and effects on human health We also welcome systematic reviews and meta-analyses of existing studies in the literature, provided these are objective and scientifically valid Food in this context is defined as materials of plant, animal or mineral origin, which are consumed orally (by humans) for pleasure and to sustain growth and vital processes. Examples of research topics that are of interest to be published in Food & Function are: Chemistry and physics of food components and digestion processes Relationship between the physical properties/structure of food and nutrition and human health - for example, impact of food matrix or processing on nutrient release and uptake Molecular properties and physiological effects of food components (nutrients, fibres, essential micronutrients, phytochemicals, bioactives, food substitutes, novel ingredients, allergens, flavours and fragrances) Nutritional and health effects of food including bioavailability and metabolism assessment of food components (nutrients, micronutrients and other microconstituents) Efficacy and mechanisms of food constituents in the body - including biomarkers of intakes, exposure and effects Impacts of foods/food components on gut microorganisms and human physiology - For example impact of fermented foods Role of nutrition and diet in human disease prevention and development Cellular and molecular effects/mechanisms of food/food components image block The following types of research are not within the scope of Food & Function: Research relating to traditional herbal medicines, medicinal plants or active compounds extracted from such plants (materials that are primarily consumed as medicine, i.e. the intended purpose is primarily to treat, cure or prevent a non-deficiency disease) or relating to foods not recognised as human diet contributors Animal nutrition research that is not primarily designed as a model to benefit human nutrition (for example, studies of growth/accretion, heat stress, weaning, ruminant digestion, meat quality, etc.) Treatments administered by non-oral routes such as injection (subcutaneous, intramuscular, intraperitoneal, etc.), dermal/transdermal, rectal, inhalation, nasal, etc. Exceptions are when such routes of administration are used for mechanistic/control purposes in the experimental design Pharmacological/pharmaceutical approaches: Encapsulation, emulsification and/or pure controlled release of compounds or bioactives that do not come directly from edible foods, such as dietary supplements - these are better suited to a pharmaceutical journal In vitro or in vivo studies with poorly defined (insufficiently characterised) extracts and studies without appropriate controls will not be considered Cells studies not considering the metabolism of food components ingested – for example, irrelevant exposure of cells to compounds not present in the body after absorption Manuscripts with only a fully theoretical/bioinformatic approach and without appropriate support from analytical evidence will not be considered for publication Studies focussing solely on food engineering, preservation and sustainable technologies – these can be published in our companion journal Sustainable Food Technology Pure food analysis - these can be published in Analytical Methods

おすすめサプライヤー

免責事項
このページに表示される学術雑誌情報は、参考および研究目的のみを目的としています。当社は雑誌出版社とは提携しておらず、投稿の取り扱いも行っておりません。出版に関するお問い合わせは、各雑誌出版社に直接ご連絡ください。
表示されている情報に誤りがある場合は、support@chemtradehub.com までご連絡ください。迅速に確認し、対応いたします。